Rybelsus Headache: How Common, How Long It Lasts, What Helps
The Rybelsus label does not list headache as a side effect. What people mean by it: pain in the head.
- In the label
- Not listed
- Most common in the label
- Nausea 20%
A quick look at Rybelsus
Its half-life is about 1 week. After 7 d, half is gone; five half-lives (35 d) leave about 3%.
In PIONEER 1, which lasted 26 weeks in people with type 2 diabetes, 3.7 kg was lost, compared with 1.4 kg on placebo.
The maker's price page provides monthly price points in US dollars for list prices and self-pay offers.
Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.
What the Rybelsus label lists instead
The Rybelsus label does not list headache. The label reports these five side effects most often.
| Side effect | Placebo | Rybelsus 7 mg | Rybelsus 14 mg | More than placebo, 14 mg |
|---|---|---|---|---|
| Nausea | 6% | 11% | 20% | +14 points |
| Abdominal Pain | 4% | 10% | 11% | +7 points |
| Diarrhea | 4% | 9% | 10% | +6 points |
| Decreased appetite | 1% | 6% | 9% | +8 points |
| Vomiting | 3% | 6% | 8% | +5 points |
Source: Rybelsus label (DailyMed).
Headache on Rybelsus: a comparison with other GLP-1s
Each label covers its own trials, which involved different groups of people. Use this as a rough guide.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
 Wegovy | 14% | 2.4 mg | 10% | Adults with obesity or overweight (weight management) |
 Saxenda | 13.6% | all doses | 12.6% | Adults with obesity or overweight (weight management) |
 Victoza | 11% | 1.2 mg | 7% | Adults with type 2 diabetes |
 Foundayo | 9% | 9 mg | 7% | Adults with obesity or overweight (weight management) |
| Byetta | 9% | all doses | 6% | Adults with type 2 diabetes |
 Ozempic | Not listed | – | – | – |
| Rybelsus | Not listed | – | – | – |
 Mounjaro | Not listed | – | – | – |
 Zepbound | Not listed | – | – | – |
 Trulicity | Not listed | – | – | – |
Sources: Wegovy label (DailyMed), Foundayo label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), and Byetta label (DailyMed).
Drawn from the FDA DailyMed label.